Abstract
Phosphodiesterase 4 (PDE4) is a promising target for the treatment of Parkinson's disease (PD). However, the underlying mechanism has not yet been well elucidated. Additionally, most of current PDE4 inhibitors produce severe nausea and vomiting response in patients, which limit their clinical application. FCPR16 is a novel PDE4 inhibitor with little emetic potential. In the present study, the neuroprotective effect and underlying mechanism of FCPR16 against cellular apoptosis induced by 1-methyl-4-phenylpyridinium (MPP+) were examined in SH-SY5Y cells. FCPR16 (12.5-50 μM) dose-dependently reduced MPP+-induced loss of cell viability, accompanied by reductions in nuclear condensation and lactate dehydrogenase release. The level of cleaved caspase 3 and the ratio of Bax/Bcl-2 were also decreased after treatment with FCPR16 in MPP+-treated cells. Furthermore, FCPR16 (25 μM) significantly suppressed the accumulation of reactive oxygen species (ROS), prevented the decline of mitochondrial membrane potential (Δψm) and attenuated the expression of malonaldehyde level. Further studies disclosed that FCPR16 enhanced the levels of cAMP and the exchange protein directly activated by cAMP (Epac) in SH-SY5Y cells. Western blotting analysis r...Continue Reading
Citations
Nov 9, 2018·The International Journal of Neuropsychopharmacology·Hui YuHaitao Wang
Jan 24, 2020·British Journal of Pharmacology·Jiahong ZhongHaitao Wang
Jun 15, 2018·International Journal of Molecular Medicine·Yunlu JiangBo Bai
Jun 27, 2019·Free Radical Research·Ya LiFangxia Guan
Dec 20, 2018·Frontiers in Pharmacology·Qingxia HuangJian Wang
May 10, 2019·Frontiers in Pharmacology·Cong GaiHong-Mei Sun
Nov 11, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Da Hye SongJeung Hee An
Dec 31, 2019·Oxidative Medicine and Cellular Longevity·Hai-Fan YuBin Guo
Sep 22, 2020·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Xiang SunShizhong Zhang
Sep 18, 2020·Antioxidants & Redox Signaling·Xiangzhan ZhuBianhong Zhang
Jan 8, 2021·Frontiers in Neuroscience·Kunwadee NoonongKulathida Chaithirayanon
Dec 29, 2020·Free Radical Biology & Medicine·Bingtian XuHaitao Wang
Dec 15, 2020·Journal of Cellular and Molecular Medicine·Yajuan NiJingwen Zhang
Feb 12, 2021·Journal of the Science of Food and Agriculture·Juan KanChangHai Jin
Mar 7, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Ratchaneekorn ReudhabibadhPilaiwanwadee Hutamekalin
Jul 10, 2020·International Immunopharmacology·Baoyue ZhangGuanhua Du
Jul 17, 2020·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Abid BhatMeena Kishore Sakharkar
Apr 4, 2021·Antioxidants·Saray VaronaCristina Rodríguez
Apr 28, 2021·The European Journal of Neuroscience·Yaohua ChenOumei Cheng
Jun 3, 2021·Materials·Muhammad HarrisMuhammad Shahzad
Aug 4, 2021·Food & Function·Han Deng, ZeGang Ma
Dec 3, 2020·ACS Chemical Neuroscience·Abid BhatGilles J Guillemin
Sep 22, 2018·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Yan WangXiaoqiu Liang